Vera Therapeutics, Inc. · NASDAQ:VERA
The Vanguard Group reported a 5.03% stake in Vera Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.03% stake in Vera Therapeutics, Inc., 3,570,401 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.03%
- Shares
- 3,570,401
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.03% | 3,570,401 |
Source
Related
- Vera Therapeutics, Inc.
- The Vanguard Group
- Vera Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Fordyce Marshall · Sep 17, 2026
- Form 4 · Young Joseph R · Sep 14, 2026
- Form 4 · Fordyce Marshall · Sep 4, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026